Technical Analysis for BNGO - Bionano Genomics, Inc.

Grade Last Price % Change Price Change
D 4.41 -6.96% -0.33
BNGO closed down 6.96 percent on Thursday, May 13, 2021, on approximately normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
103 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down
Historical BNGO trend table...

Date Alert Name Type % Chg
New Downtrend Bearish 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
180 Bearish Setup Bearish Swing Setup -6.96%
Inside Day Range Contraction -6.96%
Wide Bands Range Expansion -6.96%
Oversold Stochastic Weakness -6.96%
Stochastic Buy Signal Bullish -13.87%
Wide Bands Range Expansion -13.87%
Lower Bollinger Band Touch Weakness -13.87%
Older End-of-Day Signals for BNGO ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Lower Bollinger Band Support about 5 hours ago
Down 5% about 8 hours ago
Down 3% about 9 hours ago
Down 2 % about 9 hours ago
Down 1% about 9 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Bionano Genomics, Inc. Description

BioNano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The company develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. Its Saphyr system comprises an instrument, chip consumables, reagents, and a suite of data analysis tools. BioNano Genomics, Inc. also provides Bionano prep kits and labeling kits that provide the critical reagents and protocols needed to extract and label high molecular weight, or HMW, DNA for use with the Saphyr system; and data solutions that includes a suite of hardware and software for experiment management, algorithms for assembling genome maps, and algorithms and databases for bioinformatics processing. The company was formerly known as BioNanomatrix, Inc. and changed its name to BioNano Genomics, Inc. in October 2011. The company was founded in 2003 and is headquartered in San Diego, California.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Genetics Genomics Algorithms Informatics Genome Maps Bioinformatics Cytogenetics

Is BNGO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 15.69
52 Week Low 0.3551
Average Volume 24,235,568
200-Day Moving Average 4.16
50-Day Moving Average 7.12
20-Day Moving Average 5.81
10-Day Moving Average 5.37
Average True Range 0.66
ADX 26.05
+DI 14.65
-DI 34.26
Chandelier Exit (Long, 3 ATRs ) 5.74
Chandelier Exit (Short, 3 ATRs ) 6.28
Upper Bollinger Band 7.40
Lower Bollinger Band 4.23
Percent B (%b) 0.06
BandWidth 54.40
MACD Line -0.68
MACD Signal Line -0.59
MACD Histogram -0.0945
Fundamentals Value
Market Cap 675.55 Million
Num Shares 153 Million
EPS -2.76
Price-to-Earnings (P/E) Ratio -1.60
Price-to-Sales 4.82
Price-to-Book 5.10
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.37
Resistance 3 (R3) 5.44 5.19 5.21
Resistance 2 (R2) 5.19 4.95 5.16 5.16
Resistance 1 (R1) 4.80 4.79 4.68 4.73 5.10
Pivot Point 4.55 4.55 4.49 4.52 4.55
Support 1 (S1) 4.16 4.31 4.04 4.09 3.72
Support 2 (S2) 3.91 4.15 3.88 3.66
Support 3 (S3) 3.52 3.91 3.61
Support 4 (S4) 3.45